In a first of its kind decision, a St. Louis jury not only found that evidence indicated that Johnson & Johnson talcum powder caused a woman’s fatal ovarian cancer but also that the company knew about the possible dangers associated with its use. The jury found that Johnson & Johnson completely failed to act on this information and was ordered to pay some $72 million ...
Jury Finds Definitive Link Between Johnson & Johnson Talc and Cancer
Posted March 8, 2016 in Product News and Recalls
J&J Touts Ambitious Drug Pipeline Despite Legal Troubles
Posted June 2, 2015 in Drug and Medical Device Lawsuits | Product News and Recalls
The global pharmaceutical giant Johnson & Johnson has revealed its plans to seek regulatory approval for 10 new drugs by 2019, Bloomberg reports. The company is expecting potential annual sales of $1 billion for each new drug. These blockbuster products would provide a much-needed revenue boost for Johnson & Johnson’s drug division, Janssen Pharmaceutical, which is embroiled not only in fierce ...
J&J to Pay $7.8 Million in Arkansas Risperdal Lawsuit
Posted May 29, 2015 in Product News and Recalls | Verdicts & Settlements
Pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a seven-and-a-half-year-old Risperdal lawsuit, the Arkansas Democrat-Gazette reports. The state of Arkansas filed the lawsuit in 2007, alleging that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, unlawfully marketed its antipsychotic drug Risperdal to Arkansas doctors.
The lawsuit claimed that Johnson & Johnson put patients at risk by not fully disclosing the ...
continue reading...Costco Wholesale Corp. has filed a lawsuit against Johnson & Johnson, accusing the medical device and drug giant’s Vision Care, Inc., of engaging in price fixing with its contact lenses, The Wall Street Journal reports. The lawsuit was made public in Johnson & Johnson’s recent quarterly report to the U.S. Securities and Exchange Commission.
According to the report, Costco filed the complaint in March of ...
continue reading...MA Court Upholds $63 Million Motrin Verdict
Posted May 7, 2015 in Product News and Recalls
The Massachusetts Supreme Judicial Court has upheld a $63 million lawsuit brought against pharmaceutical giant Johnson & Johnson by the family of a girl who developed the life-threatening skin condition known as SJS/TEN after taking Children’s Motrin.
In 2003, the seven-year-old Massachusetts girl developed a rare but potentially fatal skin disorder called toxic epidermal necrolysis after taking Children’s Motrin. As a result of the condition, the girl lost 90 percent ...
continue reading...J&J CEO’s Pay Rises 48%
Posted April 3, 2015 in Drug and Medical Device Lawsuits | Product News and Recalls
Johnson & Johnson Chairman and Chief Executive Alex Gorsky’s total pay rose 48 percent in 2014, an article from the Wall Street Journal Reports. Board members say they made the decision based on Johnson & Johnson’s success in achieving short- and long-term financial goals and building on the momentum of its pharmaceutical business.
Despite these positive reviews, 2014 was a year fraught with ...
continue reading...
